Status:

COMPLETED

NEO Rehab Program for Premature Infants at Risk for Cerebral Palsy

Lead Sponsor:

University of Virginia

Collaborating Sponsors:

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Conditions:

Cerebral Palsy

Prematurity

Eligibility:

All Genders

23-32 years

Phase:

NA

Brief Summary

The goal of this project is to investigate the acceptability, feasibility and fidelity of an innovative NICU rehabilitation program that will include six multimodal, gestational age (GA) appropriate, ...

Detailed Description

The two following specific aims will be tested: Aim 1: Enroll 60 preterm infants (\<32 weeks' gestation and/or ≤1500 grams) with abnormal GMA into a pilot randomized control trial to evaluate the acc...

Eligibility Criteria

Inclusion

  • GA at birth: ≤32 weeks gestation and/or birthweight ≤1500 grams
  • Infants 7 days or older
  • Ability of parents or identified designated surrogate (e.g. grandparent) to perform the interventions
  • Abnormal writhing GMs defined by the presence of a poor repertoire pattern on 2 consecutive assessments or the presence of a cramped-synchronized pattern on any assessment

Exclusion

  • Clinically unstable (requiring high frequency mechanical ventilation, vasopressor support, need for continuous intravenous pain or sedation medication)
  • If their parents do not speak English
  • If parental participation is hindered (e.g. incarceration).

Key Trial Info

Start Date :

May 25 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

August 1 2021

Estimated Enrollment :

70 Patients enrolled

Trial Details

Trial ID

NCT04330859

Start Date

May 25 2019

End Date

August 1 2021

Last Update

October 15 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Virginia

Charlottesville, Virginia, United States, 22908